The biotech ingredient market size has grown strongly in recent years. It will grow from $63.25 billion in 2025 to $67.42 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing demand for natural and safe ingredients, advances in microbial fermentation technologies, growing awareness of biotech applications in food and personal care, rising consumer preference for sustainable ingredients, early adoption of yeast- and algae-based compounds.
The biotech ingredient market size is expected to see strong growth in the next few years. It will grow to $87.06 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to expansion of precision medicine and personalized nutrition, increased government support for biotech R&D, scaling up of microbial and yeast expression systems, adoption of AI and automation in production, growing application across cosmetics, cleaning products, and food industries. Major trends in the forecast period include synthetic biology advancements, microbial engineering innovations, cost-effective ingredient production, regulatory compliance & safety standards, expansion in food, personal care, and cleaning applications.
The growing demand for personal care products is expected to drive the expansion of the biotech ingredient market in the coming years. Personal care products encompass a wide range of items used to maintain personal hygiene and enhance appearance. The use of biotech ingredients in personal care products provides advantages such as a reduced environmental footprint, improved sustainability, consistent quality, lower allergenic potential, biocompatibility, enhanced efficacy, and decreased reliance on petrochemicals. For example, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, the average annual spending on personal care products and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Therefore, the rising demand for personal care products is contributing to the growth of the biotech ingredient market.
Major companies operating in the biotech ingredient market are emphasizing the development of innovative solutions, such as advanced biotechnology-based ingredient platforms, to address the growing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-enabled ingredients utilize enzymatic and bio-based processes to generate novel molecular structures with improved functionality, delivering superior performance, scalability, and environmental advantages compared with conventional chemically synthesized ingredients. For example, in March 2023, International Flavors & Fragrances Inc., a US-based producer of fragrances, biotech solutions, cosmetic actives, and health ingredients, launched Aurist AGC, a new biopolymer designed for hair care applications. This launch demonstrates the capabilities of the company’s DEB platform by leveraging IFF’s extensive biotechnology expertise to deliver long-lasting, high-performance solutions that can meaningfully contribute to advancements in the cosmeceutical industry. The ingredient is developed using IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology platform that enables the production of novel bio-based polysaccharides with unique structures and functional properties.
In July 2023, Evonik, a Germany-based specialty chemicals company, acquired Novachem for an undisclosed amount. Through this acquisition, Evonik seeks to enhance its biotech ingredient capabilities by incorporating Novachem’s natural and sustainable active ingredients and expanding its portfolio of high-value cosmetic actives. Novachem is an Argentina-based biotech company that supplies biotechnologically derived active ingredients for skin and hair care applications.
Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.
Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biotech ingredient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the biotech ingredient market by raising import costs on raw materials and specialized microbial strains, disrupting supply chains and affecting production timelines. Food, personal care, and cleaning product segments in regions such as North America, Europe, and Asia-Pacific are most impacted due to high dependency on imported biotech inputs. While costs have increased for some manufacturers, tariffs have encouraged local production, innovation in cost-efficient processes, and investment in domestic microbial production facilities, creating selective opportunities for market growth.
The biotech ingredient market research report is one of a series of new reports that provides biotech ingredient market statistics, including biotech ingredient industry global market size, regional shares, competitors with a biotech ingredient market share, detailed biotech ingredient market segments, market trends and opportunities, and any further data you may need to thrive in the biotech ingredient industry. This biotech ingredient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biotech ingredients are chemical components produced using microorganisms, most commonly yeast, yeast-like organisms, or algae, whose DNA is modified so that their metabolic processes generate commercially viable compounds. These ingredients are generally safer and often more cost-effective for consumers.
The primary types of biotech ingredients include active pharmaceutical ingredients and biosimilars. An active pharmaceutical ingredient (API) is the component of an over-the-counter or prescription medication that produces the intended therapeutic effect. The expression systems used include mammalian, microbial, yeast, plant, and insect expression systems, which are applied across various industries such as food and beverages, personal care and cosmetics, cleaning products, and other applications.
The biotech ingredient market consists of sales of shea butter, coconut oil, mango butter, frankincense essential oil, patchouli essential oil, and licorice extract. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The biotech ingredient market size is expected to see strong growth in the next few years. It will grow to $87.06 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to expansion of precision medicine and personalized nutrition, increased government support for biotech R&D, scaling up of microbial and yeast expression systems, adoption of AI and automation in production, growing application across cosmetics, cleaning products, and food industries. Major trends in the forecast period include synthetic biology advancements, microbial engineering innovations, cost-effective ingredient production, regulatory compliance & safety standards, expansion in food, personal care, and cleaning applications.
The growing demand for personal care products is expected to drive the expansion of the biotech ingredient market in the coming years. Personal care products encompass a wide range of items used to maintain personal hygiene and enhance appearance. The use of biotech ingredients in personal care products provides advantages such as a reduced environmental footprint, improved sustainability, consistent quality, lower allergenic potential, biocompatibility, enhanced efficacy, and decreased reliance on petrochemicals. For example, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, the average annual spending on personal care products and services increased from $866 per consumer unit in 2022 to $950 per consumer unit in 2023. Therefore, the rising demand for personal care products is contributing to the growth of the biotech ingredient market.
Major companies operating in the biotech ingredient market are emphasizing the development of innovative solutions, such as advanced biotechnology-based ingredient platforms, to address the growing demand for high-performance, sustainable, and next-generation cosmetic and personal care formulations. These biotechnology-enabled ingredients utilize enzymatic and bio-based processes to generate novel molecular structures with improved functionality, delivering superior performance, scalability, and environmental advantages compared with conventional chemically synthesized ingredients. For example, in March 2023, International Flavors & Fragrances Inc., a US-based producer of fragrances, biotech solutions, cosmetic actives, and health ingredients, launched Aurist AGC, a new biopolymer designed for hair care applications. This launch demonstrates the capabilities of the company’s DEB platform by leveraging IFF’s extensive biotechnology expertise to deliver long-lasting, high-performance solutions that can meaningfully contribute to advancements in the cosmeceutical industry. The ingredient is developed using IFF’s proprietary Designed Enzymatic Biopolymers (DEB) technology, an advanced biotechnology platform that enables the production of novel bio-based polysaccharides with unique structures and functional properties.
In July 2023, Evonik, a Germany-based specialty chemicals company, acquired Novachem for an undisclosed amount. Through this acquisition, Evonik seeks to enhance its biotech ingredient capabilities by incorporating Novachem’s natural and sustainable active ingredients and expanding its portfolio of high-value cosmetic actives. Novachem is an Argentina-based biotech company that supplies biotechnologically derived active ingredients for skin and hair care applications.
Major companies operating in the biotech ingredient market are Merck & Co. Inc., Sanofi S.A., AbbVie Inc., International Flavors & Fragrance (IFF) Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan Inc., Boehringer Ingelheim International GmbH., AstraZeneca plc., Givaudan, Firmenich SA, Amyris Inc., Advanced BioTech, Sollice Biotech, Novocap S.A., Eli Lilly, Bristol-Myers Squibb Company, GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Biogen Inc., Amgen Inc., Johnson & Johnson, Genentech Inc., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences Inc., BioMarin Pharmaceutical Inc., Incyte Corporation, Seattle Genetics Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Moderna Inc., Editas Medicine Inc., Intellia Therapeutics Inc., Sangamo Therapeutics Inc., Bluebird Bio Inc., Spark Therapeutics Inc.
Europe was the largest region in the biotech ingredient market in 2025. Asia-Pacific is expected to be the fastest-growing region in the biotech ingredients market report during the forecast period. The regions covered in the biotech ingredient market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the biotech ingredient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the biotech ingredient market by raising import costs on raw materials and specialized microbial strains, disrupting supply chains and affecting production timelines. Food, personal care, and cleaning product segments in regions such as North America, Europe, and Asia-Pacific are most impacted due to high dependency on imported biotech inputs. While costs have increased for some manufacturers, tariffs have encouraged local production, innovation in cost-efficient processes, and investment in domestic microbial production facilities, creating selective opportunities for market growth.
The biotech ingredient market research report is one of a series of new reports that provides biotech ingredient market statistics, including biotech ingredient industry global market size, regional shares, competitors with a biotech ingredient market share, detailed biotech ingredient market segments, market trends and opportunities, and any further data you may need to thrive in the biotech ingredient industry. This biotech ingredient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Biotech ingredients are chemical components produced using microorganisms, most commonly yeast, yeast-like organisms, or algae, whose DNA is modified so that their metabolic processes generate commercially viable compounds. These ingredients are generally safer and often more cost-effective for consumers.
The primary types of biotech ingredients include active pharmaceutical ingredients and biosimilars. An active pharmaceutical ingredient (API) is the component of an over-the-counter or prescription medication that produces the intended therapeutic effect. The expression systems used include mammalian, microbial, yeast, plant, and insect expression systems, which are applied across various industries such as food and beverages, personal care and cosmetics, cleaning products, and other applications.
The biotech ingredient market consists of sales of shea butter, coconut oil, mango butter, frankincense essential oil, patchouli essential oil, and licorice extract. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Biotech Ingredient Market Characteristics
3. Biotech Ingredient Market Supply Chain Analysis
4. Global Biotech Ingredient Market Trends and Strategies
5. Biotech Ingredient Market Analysis of End Use Industries
7. Global Biotech Ingredient Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Biotech Ingredient Total Addressable Market (TAM) Analysis for the Market
9. Biotech Ingredient Market Segmentation
10. Biotech Ingredient Market Regional and Country Analysis
11. Asia-Pacific Biotech Ingredient Market
12. China Biotech Ingredient Market
13. India Biotech Ingredient Market
14. Japan Biotech Ingredient Market
15. Australia Biotech Ingredient Market
16. Indonesia Biotech Ingredient Market
17. South Korea Biotech Ingredient Market
18. Taiwan Biotech Ingredient Market
19. South East Asia Biotech Ingredient Market
20. Western Europe Biotech Ingredient Market
21. UK Biotech Ingredient Market
22. Germany Biotech Ingredient Market
23. France Biotech Ingredient Market
24. Italy Biotech Ingredient Market
25. Spain Biotech Ingredient Market
26. Eastern Europe Biotech Ingredient Market
27. Russia Biotech Ingredient Market
28. North America Biotech Ingredient Market
29. USA Biotech Ingredient Market
30. Canada Biotech Ingredient Market
31. South America Biotech Ingredient Market
32. Brazil Biotech Ingredient Market
33. Middle East Biotech Ingredient Market
34. Africa Biotech Ingredient Market
36. Biotech Ingredient Market Competitive Landscape and Company Profiles
37. Biotech Ingredient Market Other Major and Innovative Companies
40. Biotech Ingredient Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Biotech Ingredient Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses biotech ingredient market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for biotech ingredient? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biotech ingredient market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Active Pharmaceutical Ingredients; Biosimilars2) By Expression Systems: Mammalian Expression Systems; Microbial Expression Systems; Yeast Expression Systems; Plant Expression Systems; Insect Expression Systems
3) By Application: Food And Beverages; Personal Care And Cosmetics; Cleaning Products; Other Applications
Subsegments:
1) By Active Pharmaceutical Ingredients (APIs): Biologic APIs; Synthetic APIs2) By Biosimilars: Monoclonal Antibodies; Recombinant Proteins; Insulin Biosimilars
Companies Mentioned: Merck & Co. Inc.; Sanofi S.A.; AbbVie Inc.; International Flavors & Fragrance (IFF) Inc.; Novartis AG; Pfizer Inc.; Teva Pharmaceutical Industries Ltd.; Mylan Inc.; Boehringer Ingelheim International GmbH.; AstraZeneca plc.; Givaudan; Firmenich SA; Amyris Inc.; Advanced BioTech; Sollice Biotech; Novocap S.A.; Eli Lilly; Bristol-Myers Squibb Company; GlaxoSmithKline plc.; F. Hoffmann-La Roche AG; Biogen Inc.; Amgen Inc.; Johnson & Johnson; Genentech Inc.; Regeneron Pharmaceuticals Inc.; Vertex Pharmaceuticals Incorporated; Alexion Pharmaceuticals Inc.; Celgene Corporation; Gilead Sciences Inc.; BioMarin Pharmaceutical Inc.; Incyte Corporation; Seattle Genetics Inc.; Alnylam Pharmaceuticals Inc.; Ionis Pharmaceuticals Inc.; Moderna Inc.; Editas Medicine Inc.; Intellia Therapeutics Inc.; Sangamo Therapeutics Inc.; Bluebird Bio Inc.; Spark Therapeutics Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Biotech Ingredient market report include:- Merck & Co. Inc.
- Sanofi S.A.
- AbbVie Inc.
- International Flavors & Fragrance (IFF) Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Mylan Inc.
- Boehringer Ingelheim International GmbH.
- AstraZeneca plc.
- Givaudan
- Firmenich SA
- Amyris Inc.
- Advanced BioTech
- Sollice Biotech
- Novocap S.A.
- Eli Lilly
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc.
- F. Hoffmann-La Roche AG
- Biogen Inc.
- Amgen Inc.
- Johnson & Johnson
- Genentech Inc.
- Regeneron Pharmaceuticals Inc.
- Vertex Pharmaceuticals Incorporated
- Alexion Pharmaceuticals Inc.
- Celgene Corporation
- Gilead Sciences Inc.
- BioMarin Pharmaceutical Inc.
- Incyte Corporation
- Seattle Genetics Inc.
- Alnylam Pharmaceuticals Inc.
- Ionis Pharmaceuticals Inc.
- Moderna Inc.
- Editas Medicine Inc.
- Intellia Therapeutics Inc.
- Sangamo Therapeutics Inc.
- Bluebird Bio Inc.
- Spark Therapeutics Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 67.42 Billion |
| Forecasted Market Value ( USD | $ 87.06 Billion |
| Compound Annual Growth Rate | 6.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 41 |
